Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Join IAVI at the 7th Global Forum on TB Vaccines

October 2, 2024

IAVI leaders to represent the full breadth of TB vaccine research, development, implementation, advocacy, and policy at the 7th Global Forum in Rio.

Read more

Features

IAVI at HIVR4P 2024, the 5th HIV Research for Prevention Conference

October 1, 2024

From HIV vaccine development to socio-behavioral research and community engagement in clinical trials, IAVI leaders are presenting on a range of pressing topics in HIV prevention research.

Read more

Features

First-ever Phase 2 Lassa vaccine clinical trial now fully active across West Africa

August 26, 2024

Researchers at three sites are vaccinating participants for Lassa fever, an emerging infectious disease with outbreaks in the region.

Read more

Features

Looking ahead to one of our busiest weeks of the year: IAVI at the International AIDS Conference

July 15, 2024

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

Read more

Features

IAVI signs lease on new Vaccine Design and Development Lab in Jersey City, NJ

July 10, 2024

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.

Read more

Features

Unitaid, IAVI, Medicines Patent Pool, and Wellcome publish novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

July 5, 2024

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible.

Read more

Features

World Zoonoses Day 2024: IAVI celebrates progress in Lassa vaccine development

July 5, 2024

A series of publications highlight advancements in countermeasures for Lassa fever, an animal-borne illness.

Read more

Features

Meet The Scientist podcast: An interview with Dr. Elana Van Brakel, Medical Director at IAVI, on IAVI’s TB vaccine program

June 26, 2024

In this episode of Meet the Scientist, we explore IAVI’s efforts in the late-stage development of the MTBVAC TB vaccine candidate.

Read more